At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
Recent Posts
- Join NJ ACTS for Boosted: The Impact of Science, Society, and Policy on Public Health on 2/27 at 12
- NJACTS Community Engagement Core COVID-19 Resources
- Join NJ ACTS on 2/12 at 4pm for the Pilots Program 2026 Webinar
- NJACTS Community Engagement Core Available Services
- Mental Health and Pain Medication Prescriptions for Young People Have Declined in the Past 20 Years.
Categories
- Community (2,439)
- Covid (997)
- CTO Events (6)
- News (3,089)
- Pilots (21)